Klacid Uno

Clarithromycin, the active ingredient in Klacid Uno, is a macrolide antibiotic presented as an oral dosage form for oral use. It treats bacterial infections such as community‑acquired pneumonia, acute bacterial sinusitis, skin and soft‑tissue infections, and is used in combination regimens for Helicobacter pylori eradication in adult patients.

GNH USA supplies Klacid Uno as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Clarithromycin is a macrolide antibiotic that targets a range of bacterial infections in the respiratory, sinus and skin compartments. - Community‑acquired pneumonia: effective in treating adult patients with typical bacterial pathogens. - Acute bacterial sinusitis: reduces symptoms and bacterial load in sinus infections. - Skin and soft‑tissue infections: combats Staphylococcus and Streptococcus species causing cellulitis and abscesses. - Helicobacter pylori eradication (in combination therapy): contributes to bacterial clearance when used with other agents.

Clarithromycin may cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Diarrhea: frequent loose stools. - Abdominal pain: cramping or discomfort. - Taste disturbance: altered or metallic taste. - Headache: mild tension‑type headache. - Vomiting: occasional episodes.

Serious or Rare Side Effects: - Severe allergic reactions: rash, angioedema, anaphylaxis. - Clostridioides difficile‑associated diarrhea: potentially life‑threatening colitis. - QT interval prolongation: risk of cardiac arrhythmias. - Hepatotoxicity: elevated liver enzymes or jaundice. - Cardiac arrhythmias: especially in patients with pre‑existing heart disease. - Anaphylaxis: rapid onset of systemic hypersensitivity.

Before prescribing clarithromycin, clinicians should consider several safety aspects. - Assess renal function: adjust therapy in severe impairment. - Monitor liver enzymes: watch for signs of hepatotoxicity. - Avoid use in patients with known macrolide hypersensitivity: risk of severe allergic reaction. - Consider ECG monitoring in patients with cardiac risk factors: potential QT prolongation. - Use with caution during pregnancy: limited data on fetal safety. - Store at ambient temperature: keep in the original pack, protect from moisture and light.

Clarithromycin interacts with several medicines; awareness of the interaction level guides clinical decisions.

Major Interactions (Avoid): - Cisapride: increased risk of serious cardiac arrhythmias. - Ergot alkaloids: risk of ergotism and severe vasospasm. - Theophylline: elevated plasma concentrations leading to toxicity. - Pimozide: heightened plasma levels causing extrapyramidal effects.

Moderate Interactions (Monitor Closely): - Statins (simvastatin, lovastatin): increased risk of myopathy. - Warfarin: enhanced anticoagulant effect, requiring INR monitoring. - Carbamazepine: reduced clarithromycin exposure, potentially decreasing efficacy.